Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
The following stocks are the leading risers and fallers on AIM on Friday.
----------
AIM - WINNERS
----------
Tiger Royalties & Investments PLC, up 50% at 0.15 pence, 12-month range 0.1p-0.275p. The natural resources sector-focused investor announces that on Thursday it signed a conditional agreement to acquire the entire issued share capital of Bixby Technology Inc from Toro Consulting Ltd, which is owned by Cykel AI PLC founder Jonathan Bixby, for £325,000. Tiger Royalties also has raised £3.0 million from 3.00 billion shares at 0.1p each. The fundraising comprises a placing of 2.48 billion shares at 0.1p each, and subscriptions for 525.0 million shares at the same price. Says Toro will also subscribe for new shares in Tiger Royalties worth £325,000 in total, at the fundraise price, and will receive one warrant per share. Fundraise participants and therefore new shareholders include Premier Miton Group PLC.
----------
Ascent Resources PLC, up 21% at 2p, 12-month range 1.47p-3.85p. The oil and gas explorer and producer has acquired a 49% interest in American Helium LLC’s Utah and Colorado upstream acreage, including ‘direct interests in a proportionate share of 119,000 acres of helium-rich oil and gas licenses’, for total consideration of $2.0 million. Says this will consist of $1.8 million in new Ascent shares at 5p each, plus around $250,000 in cash. Also, Ascent intends to conduct a second distribution to shareholders with ring-fenced access to 41% of the net proceeds due from Ascent’s damages claim against the Republic of Slovenia. Announces moreover that it has raised $475,949 through issuing 7.5 million shares at 5p each, more than triple its closing price of 1.65p on Thursday.
----------
AIM - LOSERS
----------
Synairgen PLC, down 34% at 2.475p, 12-month range 2.475p-7.55p. Southampton, England-based drug discovery and biotechnology firm says it has conditionally raised £18.0 million through a subscription for 900.0 million new shares at 2p each by TFG Asset Management UK LLP ‘on behalf of the relevant funds’. Adds that it intends to raise up to £6.0 million through subscriptions by ‘certain’ directors for 1.3 million shares, and a placing and open offer for up to 298.8 million shares in total, in both cases also at 2p. Says it must raise a minimum of £2.9 million for the fundraise to proceed, with the maximum proceeds to be capped at £19 million. Says it will use the net proceeds to fund external and internal costs of a phase 2 trial of its investigational formula SNG001 in mechanically ventilated patients with confirmed respiratory viral infections.
----------
Copyright 2024 Alliance News Ltd. All Rights Reserved.